Actinium Pharmaceuticals (ATNM)

Actinium Pharmaceuticals (ATNM) Financial Statements


Actinium Pharmaceuticals Financial Overview

Actinium Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.799; its P/E ratio is -3.50; Actinium Pharmaceuticals is scheduled to report earnings on March 15, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue---$ 45.00K$ 45.00K
Gross Profit-----
EBIT$ -15.64M$ 11.58M$ -11.29M$ -9.80M$ -7.85M
EBITDA$ -15.43M$ 11.77M$ -11.13M$ -9.58M$ -7.67M
Net Income Common Stockholders$ -15.18M$ 12.13M$ -10.65M$ -9.47M$ -7.77M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 91.28M$ 94.92M$ 109.31M$ 111.81M$ 116.33M
Total Assets$ 99.05M$ 101.40M$ 113.59M$ 116.82M$ 121.80M
Total Debt$ 9.15M$ 7.86M$ 10.63M$ 2.60M$ 2.65M
Net Debt$ -82.13M$ -87.06M$ -98.68M$ -109.21M$ -113.68M
Total Liabilities$ 45.97M$ 44.82M$ 47.71M$ 45.56M$ 43.62M
Stockholders Equity$ 53.08M$ 57.21M$ 66.48M$ 71.25M$ 78.18M
Cash Flow-
Free Cash Flow$ -13.69M$ -15.15M$ -7.79M$ -5.79M$ 27.65M
Operating Cash Flow$ -13.64M$ -15.08M$ -7.78M$ -5.71M$ 27.92M
Investing Cash Flow$ -47.00K$ -76.00K$ -16.00K$ -73.00K$ -270.00K
Financing Cash Flow$ 10.05M$ 770.00K$ 4.89M$ 1.57M$ 16.66M
Currency in USD

Actinium Pharmaceuticals Earnings and Revenue History

Actinium Pharmaceuticals Debt to Assets

Actinium Pharmaceuticals Cash Flow

Actinium Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis